Correction: In vitro and in vivo antiproliferative activity of organo-nickel SCS-pincer complexes on estrogen responsive MCF7 and MC4L2 breast cancer cells. Effects of amine fragment substitutions on BSA binding and cytotoxicity.

Correction for 'In vitro and in vivo antiproliferative activity of organo-nickel SCS-pincer complexes on estrogen responsive MCF7 and MC4L2 breast cancer cells. Effects of amine fragment substitutions on BSA binding and cytotoxicity' by Mahboubeh Hosseini-Kharat et al., Dalton Trans., 2018, 47, 16944-16957, https://doi.org/10.1039/c8dt03079k.

Endosteal substitution with medial plate in the treatment of acute distal femur fracture (AO/OTA type A): surgical technique and case-series.

INTRODUCTION: Distal Femur fractures account for 4- 6% of all femur fractures and can be challenging to treat. The aims of this study are: (1) to describe a surgical technique using a medial distal femur endosteal plate to augment the stability of standard lateral plate fixation; (2) to report the results of a case-series of acute distal femur fractures (AO/OTA Type A/ Vancouver periprosthetic fractures Type C) treated using this technique. METHODS: This study describes the surgical steps for placement of a medial endosteal plate in combination with lateral locking plate in a cadaver model using fluoroscopy guidance. In addition, a retrospective database chart review for all patients with acute distal femur fractures treated with this technique over the last five years was performed. Exclusion criteria were involvement of type B and C distal femur intraarticular fractures, treatment with other endosteal substitutions (i.e., intramedullary nail fixation and fibula allograft), and treatment for non-union or pathological fractures. RESULTS: Twelve patients were identified with mean age of 75 years. All patients were female and all of them were allowed full weight bearing and full range of motion exercises immediately post-operatively. The complete follow up for one patient was not available; however, the mean fracture union was confirmed at 3.8 months in 10 of 12 patients. One patient had a failed construct at three months in the context of a periprosthetic fracture with a loose implant that was initially thought to be stable. One acute superficial surgical site infection was reported and healed uneventfully following debridement, primary closure, and antibiotic treatment. CONCLUSION: We believe that the placement of a medial endosteal plate can be a useful augment for standard lateral plate fixation in acute distal femur fractures, particularly in the context of severe comminution or poor bone quality. Uneventful healing was confirmed in 10 of 12 cases and no patients were restricted with regard to motion or weight bearing immediately post-operatively. Further studies with larger sample size would be required to fully assess this technique. LEVEL OF EVIDENCE: IV. Therapeutic Study (Surgical technique and Cases-series).

C-O and C-N Functionalization of Cationic, NCN-Type Pincer Complexes of Trivalent Nickel: Mechanism, Selectivity, and Kinetic Isotope Effect.

This report presents the synthesis of new mono- and dicationic NCN-NiIII complexes and describes their reactivities with protic substrates. (NCN is the pincer-type ligand κ N, κ C, κ N-2,6-(CH2NMe2)2-C6H3.) Treating van Koten's trivalent complex (NCN)NiIIIBr2 with AgSbF6 in acetonitrile gives the dicationic complex [(NCN)NiIII(MeCN)3]2+, whereas the latter complex undergoes a ligand-exchange reaction with (NCN)NiIIIBr2 to furnish the related monocationic complex [(NCN)NiIII(Br)(MeCN)]+. These trivalent complexes have been characterized by X-ray diffraction analysis and EPR spectroscopy. Treating these trivalent complexes with methanol and methylamine led, respectively, to C-OCH3 or C-NH(CH3) functionalization of the Ni-aryl moiety in these complexes, C-heteroatom bond formation taking place at the ipso-C. These reactions also generate the cationic divalent complex [(NCN)NiII(NCMe)]+, which was prepared independently and characterized fully. The unanticipated formation of the latter divalent species suggested a comproportionation side reaction between the cationic trivalent precursors and a monovalent species generated at the C-O and C-N bond formation steps; this scenario was supported by direct reaction of the trivalent complexes with the monovalent compound (PPh3)3NiICl. Kinetic measurements and density functional theory analysis have been used to investigate the mechanism of these C-O and C-N functionalization reactions and to rationalize the observed inverse kinetic isotope effect in the reaction of [(NCN)NiIII(Br)(MeCN)]+ with CH3OH/CD3OD.

In vitro and in vivo antiproliferative activity of organo-nickel SCS-pincer complexes on estrogen responsive MCF7 and MC4L2 breast cancer cells. Effects of amine fragment substitutions on BSA binding and cytotoxicity.

A family of organonickel complexes has been prepared, fully characterized, and tested for their antiproliferative activity against estrogen-responsive human breast cancer cells (MCF7). The three SCS-type pincer ligands HL1, HL2, and HL3 and their corresponding Ni(ii) complexes NiL1, NiL2, and NiL3 have been synthesized and fully characterized, including by single crystal diffraction studies for the complexes. The complexes possess square planar geometry with two symmetrical 5-membered nickellacycles. Fluorescence spectroscopy, circular dichroism measurements, molecular modeling, colorimetric based assay and tumor transplantation studies were used to evaluate the protein binding and antiproliferative activities of these organometallic complexes both in vitro and in vivo. Fluorescence quenching was used to investigate bovine serum albumin (BSA) interaction at different temperatures (293, 303 and 313 K), and the results were analyzed using the classical Stern-Volmer equation, allowing us to propose a dynamic quenching mechanism. Studies in vitro on the antiproliferative activity of the three organonickel complexes against estrogen-responsive human breast cancer cells (MCF7) showed promising antitumor activity for NiL1 containing pyrrolidine fragments. In vivo administration of this compound significantly inhibits tumor growth in estrogen-dependent MC4L2 cancer cells in female BALB/c mice.